A study presented today at the AATS 102nd Annual Meeting reports that intentionally prolonging the cold static preservation (CSP) of a donor lung at 10°C (12-24h) is clinically safe and feasible.
Stanley C. Jordan, MD, director of the Cedars-Sinai Nephrology and Transplant Immunology programs in the Cedars-Sinai Comprehensive Transplant Center, has been elected to the Association of American Physicians (AAP).
In the search for eternal youth, poo transplants may seem like an unlikely way to reverse the ageing process.
Researchers at Washington University School of Medicine in St. Louis have received a $6 million grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health (NIH) to harness new understandings of the immune system to develop innovative therapies for heart failure and the prevention of organ rejection following heart transplantation.
Young adults who received organ transplants as children may not be regularly attending their doctor appointments after leaving their pediatric providers. Missing these appointments is associated with longer and more frequent hospitalizations and poorer medication adherence, according to a new study.
Cardiologists and cardiothoracic surgeons from the Smidt Heart Institute at Cedars-Sinai are available to discuss the latest advances in research, clinical care, transcatheter procedures and cardiothoracic surgery throughout the International Society for Heart and Lung Transplantation (ISHLT) Scientific Sessions 2022 and Heart Rhythm 2022.
“The only way out of this is with new lungs.” That’s what Andy Wilkins and his wife Michelle were told after Andy was hospitalized with COVID-19.
The risk of major complications for people who donate a kidney via laparoscopic surgery is minimal. That is the conclusion of a 20-year Mayo Clinic study of more than 3,000 living kidney donors. Only 2.5% of patients in the study experienced major complications, and all recovered completely.
The 2022 Annual Report from the Smidt Heart Institute at Cedars-Sinai is available now, detailing the latest research and medical achievements by the expert team ranked No. 1 for cardiology and cardiac surgery in California by U.S. News & World Report.
A new initiative called Pluralist will challenge the current paradigm and pursue equity in organ transplantation. The effort will place particular emphasis on communities of color in Sacramento and throughout California by using education intervention tools like social networks and digital media.
Rutgers Cancer Institute of New Jersey and RWJBarnabas Health have appointed Ira Braunschweig, MD, as chief, Section of Transplant and Cell Therapy at Rutgers Cancer Institute, chief of the Transplant and Cell Therapy Service of the RWJBarnabas Health Oncology Service Line, and director for Cell Therapy and Bone Marrow Transplantation at Robert Wood Johnson University Hospital, an RWJBarnabas facility.
Development of an implantable artificial heart that operates wirelessly and reliably for 10 years is the goal of an ongoing Penn State College of Medicine project.
This Donate Life Month, the Nettleton and Conklin families are celebrating nearly 16 years of being family.
Black kidney transplant recipients have a faster clearance rate of the immunosuppressive drug tacrolimus than white recipients, according to a new study led by the University at Buffalo. The study, published earlier this year in Pharmacotherapy, is one of the first to examine how both race and sex influence tacrolimus pharmacokinetics.
去年早些时候，Veronica Ciudad-Real被诊断出患有多发性骨髓瘤，一种她从未听说过的血癌，这让她感到非常惊讶和困惑。她才40岁，比该疾病的大多数患者都要年轻。随后她又了解到，在她的祖国萨尔瓦多无法获得她所需的治疗。
عندما تم تشخيص فيرونيكا سيوداد ريال في أوائل العام الماضي بالورم النقوي المتعدد، وهو سرطان دم لم تسمع به من قبل، كان لديها أسئلة بلا إجابات. لقد كانت في الأربعين من عمرها، أي أصغر من معظم المصابين بالمرض.
Quando Veronica Ciudad-Real foi diagnosticada no começo do ano passado com mieloma múltiplo, um câncer do sangue do qual ela nunca tinha ouvido falar, ela teve mais perguntas do que respostas. Aos 40 anos, ela era mais jovem do que a maioria das pessoas com essa doença.
Cuando Verónica Ciudad-Real recibió a principios del año el diagnóstico de mieloma múltiple, cáncer de la sangre del cual ella nunca había escuchado hablar, tuvo muchas preguntas y pocas respuestas. A sus 40 años, era más joven que la mayoría de las personas que sufren de esta enfermedad.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
